Institute for Wealth Management’s Anika Therapeutics ANIK Stock Holding History

Institute for Wealth Management’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.52K	Buy	+104	New	+$1.54K	﹤0.01%	1625

Other funds holding ANIK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Indivisible Partners Clearwater, Florida $1.77B AUM

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Institute for Wealth Management's ANIK Position: Q2 2026 in Review

Institute for Wealth Management opened a new position in Anika Therapeutics (ANIK) in Q2 2026: 104 shares worth $1.52K. The stake represents ﹤0.01% of the portfolio and ranks #1625 among its holdings.

46 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

Institute for Wealth Management held 104 shares of Anika Therapeutics worth $1.52K as of Q2 2026.
Anika Therapeutics was a new Institute for Wealth Management position in Q2 2026.
Anika Therapeutics made up ﹤0.01% of Institute for Wealth Management's portfolio in Q2 2026, its #1625 holding.
46 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Institute for Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.